- call +1-201-465-4211
- email sales@mrinsights.biz
Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.
Scope of the Report:
This report focuses on the IBS Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.
The worldwide market for IBS Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Allergan Plc (Ireland)
Sucampo Pharmaceuticals (U.S.)
Ironwood Pharmaceuticals, Inc. (U.S.)
Astellas Pharma Inc. (Japan)
Valeant Pharmaceuticals (Canada)
Abbott Laboratories (U.S.)
Synergy Pharmaceuticals, Inc. (U.S.)
Ardelyx, Inc. (U.S.)
Nestle (Switzerland)
Sebela Pharmaceuticals (Ireland)
Probi (Sweden)
Alfasigma USA, Inc. (Italy)
RedHill Biopharma Ltd. (Israel)
AstraZeneca (U.K)
Ipsen (France)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Ltd (Japan)
Synthetic Biologics, Inc. (U.S.)
Protagonist Therapeutics Inc. (U.S.)
Pfizer Inc (U.S.)
Lexicon Pharmaceuticals, Inc. (U.S.)
Innovate Biopharmaceuticals (U.S.)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
IBS-D
IBS-C
IBS-M
Market Segment by Applications, can be divided into
Hospitals
Clinics
Research Laboratories
There are 15 Chapters to deeply display the global IBS Treatment market.
Chapter 1, to describe IBS Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of IBS Treatment, with sales, revenue, and price of IBS Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of IBS Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, IBS Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe IBS Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 IBS Treatment Introduction
1.2 Market Analysis by Type
1.2.1 IBS-D
1.2.2 IBS-C
1.2.3 IBS-M
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Research Laboratories
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan Plc (Ireland)
2.1.1 Business Overview
2.1.2 IBS Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Plc (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sucampo Pharmaceuticals (U.S.)
2.2.1 Business Overview
2.2.2 IBS Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Ironwood Pharmaceuticals, Inc. (U.S.)
2.3.1 Business Overview
2.3.2 IBS Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astellas Pharma Inc. (Japan)
2.4.1 Business Overview
2.4.2 IBS Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astellas Pharma Inc. (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valeant Pharmaceuticals (Canada)
2.5.1 Business Overview
2.5.2 IBS Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Valeant Pharmaceuticals (Canada) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott Laboratories (U.S.)
2.6.1 Business Overview
2.6.2 IBS Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Laboratories (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Synergy Pharmaceuticals, Inc. (U.S.)
2.7.1 Business Overview
2.7.2 IBS Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ardelyx, Inc. (U.S.)
2.8.1 Business Overview
2.8.2 IBS Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ardelyx, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nestle (Switzerland)
2.9.1 Business Overview
2.9.2 IBS Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nestle (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sebela Pharmaceuticals (Ireland)
2.10.1 Business Overview
2.10.2 IBS Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Probi (Sweden)
2.11.1 Business Overview
2.11.2 IBS Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Probi (Sweden) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Alfasigma USA, Inc. (Italy)
2.12.1 Business Overview
2.12.2 IBS Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Alfasigma USA, Inc. (Italy) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 RedHill Biopharma Ltd. (Israel)
2.13.1 Business Overview
2.13.2 IBS Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 RedHill Biopharma Ltd. (Israel) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 AstraZeneca (U.K)
2.14.1 Business Overview
2.14.2 IBS Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 AstraZeneca (U.K) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ipsen (France)
2.15.1 Business Overview
2.15.2 IBS Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ipsen (France) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Novartis AG (Switzerland)
2.16.1 Business Overview
2.16.2 IBS Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Novartis AG (Switzerland) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Takeda Pharmaceutical Company Ltd (Japan)
2.17.1 Business Overview
2.17.2 IBS Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Synthetic Biologics, Inc. (U.S.)
2.18.1 Business Overview
2.18.2 IBS Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Synthetic Biologics, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Protagonist Therapeutics Inc. (U.S.)
2.19.1 Business Overview
2.19.2 IBS Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Protagonist Therapeutics Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Pfizer Inc (U.S.)
2.20.1 Business Overview
2.20.2 IBS Treatment Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Pfizer Inc (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Lexicon Pharmaceuticals, Inc. (U.S.)
2.21.1 Business Overview
2.2.2 IBS Treatment Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Innovate Biopharmaceuticals (U.S.)
2.22.1 Business Overview
2.22.2 IBS Treatment Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global IBS Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global IBS Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global IBS Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 IBS Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 IBS Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global IBS Treatment Market Analysis by Regions
4.1 Global IBS Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global IBS Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global IBS Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America IBS Treatment Sales and Growth Rate (2013-2018)
4.3 Europe IBS Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific IBS Treatment Sales and Growth Rate (2013-2018)
4.5 South America IBS Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa IBS Treatment Sales and Growth Rate (2013-2018)
5 North America IBS Treatment by Countries
5.1 North America IBS Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America IBS Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America IBS Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States IBS Treatment Sales and Growth Rate (2013-2018)
5.3 Canada IBS Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico IBS Treatment Sales and Growth Rate (2013-2018)
6 Europe IBS Treatment by Countries
6.1 Europe IBS Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe IBS Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe IBS Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany IBS Treatment Sales and Growth Rate (2013-2018)
6.3 UK IBS Treatment Sales and Growth Rate (2013-2018)
6.4 France IBS Treatment Sales and Growth Rate (2013-2018)
6.5 Russia IBS Treatment Sales and Growth Rate (2013-2018)
6.6 Italy IBS Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific IBS Treatment by Countries
7.1 Asia-Pacific IBS Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific IBS Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific IBS Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China IBS Treatment Sales and Growth Rate (2013-2018)
7.3 Japan IBS Treatment Sales and Growth Rate (2013-2018)
7.4 Korea IBS Treatment Sales and Growth Rate (2013-2018)
7.5 India IBS Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia IBS Treatment Sales and Growth Rate (2013-2018)
8 South America IBS Treatment by Countries
8.1 South America IBS Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America IBS Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America IBS Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil IBS Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina IBS Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia IBS Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa IBS Treatment by Countries
9.1 Middle East and Africa IBS Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa IBS Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa IBS Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia IBS Treatment Sales and Growth Rate (2013-2018)
9.3 UAE IBS Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt IBS Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria IBS Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa IBS Treatment Sales and Growth Rate (2013-2018)
10 Global IBS Treatment Market Segment by Type
10.1 Global IBS Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global IBS Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global IBS Treatment Revenue and Market Share by Type (2013-2018)
10.2 IBS-D Sales Growth and Price
10.2.1 Global IBS-D Sales Growth (2013-2018)
10.2.2 Global IBS-D Price (2013-2018)
10.3 IBS-C Sales Growth and Price
10.3.1 Global IBS-C Sales Growth (2013-2018)
10.3.2 Global IBS-C Price (2013-2018)
10.4 IBS-M Sales Growth and Price
10.4.1 Global IBS-M Sales Growth (2013-2018)
10.4.2 Global IBS-M Price (2013-2018)
11 Global IBS Treatment Market Segment by Application
11.1 Global IBS Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Research Laboratories Sales Growth (2013-2018)
12 IBS Treatment Market Forecast (2018-2023)
12.1 Global IBS Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 IBS Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America IBS Treatment Market Forecast (2018-2023)
12.2.2 Europe IBS Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific IBS Treatment Market Forecast (2018-2023)
12.2.4 South America IBS Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa IBS Treatment Market Forecast (2018-2023)
12.3 IBS Treatment Market Forecast by Type (2018-2023)
12.3.1 Global IBS Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global IBS Treatment Market Share Forecast by Type (2018-2023)
12.4 IBS Treatment Market Forecast by Application (2018-2023)
12.4.1 Global IBS Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global IBS Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure IBS Treatment Picture
Table Product Specifications of IBS Treatment
Figure Global Sales Market Share of IBS Treatment by Types in 2017
Table IBS Treatme
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
